Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients ; volume:14 ; number:3 ; day:8 ; month:1 ; year:2011 ; pages:253-258 ; date:9.2011
Pituitary ; 14, Heft 3 (8.1.2011), 253-258, 9.2011
- Urheber
-
Neggers, Sebastian J. C. M. M.
Herder, Wouter W. de
Feelders, Richard A.
Lely, A. J. van der
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11102-010-0289-5
- URN
-
urn:nbn:de:101:1-2503010610320.242301811244
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
08.09.2022, 14:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Neggers, Sebastian J. C. M. M.
- Herder, Wouter W. de
- Feelders, Richard A.
- Lely, A. J. van der
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism
Long-Acting Reversible Contraception
Somatostatin analogs in cancer management : 16 tables
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study
Creation of a long-acting nanoformulated dolutegravir
Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism
Long-Acting Reversible Contraception
Somatostatin analogs in cancer management : 16 tables
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study
Creation of a long-acting nanoformulated dolutegravir
Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story
Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism
Long-Acting Reversible Contraception
Somatostatin analogs in cancer management : 16 tables
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study